Highlights From the 2016 European Society for Medical Oncology Annual Congress

In this text module with an accompanying downloadable highlights slideset experts review the most clinically relevant study results presented at the 2016 ESMO annual meeting across multiple tumor types including advanced NSCLC melanoma breast cancer ovarian cancer and glioblastoma.

Share

Supporters

AbbVie

Genentech Roche Virology

Incyte

Merck Oncology